|11/24/15||Xtant™ Medical To Present at the 8th Annual LD Micro Conference|
|BELGRADE, Mont., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today announced that its Chief Executive Officer, Dan Goldberger and Chief Financial Officer, John Gandolfo will present at the 8th Annual LD Micro Main Event, to be held December 1-3, 2015 at the Luxe Sunset Hotel in Los Angeles, CA. Xtant Medical's presentat... |
|11/11/15||Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results|
|Third Quarter 2015 Consolidated Pro Forma Highlights:
Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014.
Excluding OEM revenue, third quarter 2015 consolidated pro forma revenue increased 13.8% to $20.2 million from $17.7 million in the third quarter of 2014.
Consolidated pro forma biologics revenue increased 15.5% to $9.8 million from $8.5 million in the third quarter of 2014.
Consolidated pro forma fixatio... |
|11/03/15||Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty|
|BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical implantation of OsteoSelect PLUS Demineralized Bone Matrix (DBM) Putty, developed by its wholly owned subsidiary, Bacterin International, Inc.OsteoSelect PLUS is a next-generation DBM putty, comprised of OsteoSelect DBM Putty and demineralized cortical chips, designed to provide sup... |
|11/02/15||Xtant Medical Holdings, Inc. to Report Third Quarter 2015 Financial Results on November 11, 2015|
|BELGRADE, Mont., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the period ended September 30, 2015, at the close of the financial markets on November 11, 2015.
An accompanying conference call will be hosted by Dan Goldberger, Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss the results. Th... |